Fennec Pharmaceuticals (FENC) Net Cash Flow Growth (3y) (2013 - 2025)
Fennec Pharmaceuticals (FENC) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.47% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 64.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.88% |
| Sep 30, 2025 | -39.77% |
| Jun 30, 2025 | -5.89% |
| Mar 31, 2025 | -11.70% |
| Dec 31, 2024 | -61.73% |
| Sep 30, 2024 | 2.59% |
| Jun 30, 2024 | -22.47% |
| Mar 31, 2024 | 132.40% |
| Dec 31, 2023 | 32.16% |
| Sep 30, 2023 | 22.81% |
| Jun 30, 2023 | -28.44% |
| Mar 31, 2023 | -12.82% |
| Dec 31, 2022 | -55.50% |
| Sep 30, 2022 | 105.19% |
| Jun 30, 2022 | -6.66% |
| Mar 31, 2022 | -3.67% |
| Dec 31, 2021 | -22.89% |
| Sep 30, 2021 | -38.39% |
| Jun 30, 2021 | -60.08% |
| Mar 31, 2021 | -32.60% |